AU2001258755A1 - Ophthalmic solution - Google Patents

Ophthalmic solution

Info

Publication number
AU2001258755A1
AU2001258755A1 AU2001258755A AU5875501A AU2001258755A1 AU 2001258755 A1 AU2001258755 A1 AU 2001258755A1 AU 2001258755 A AU2001258755 A AU 2001258755A AU 5875501 A AU5875501 A AU 5875501A AU 2001258755 A1 AU2001258755 A1 AU 2001258755A1
Authority
AU
Australia
Prior art keywords
ophthalmic solution
pericorneal
vasoconstrictor
conjunctiva
ameliorating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258755A
Inventor
Hiroshi Aki
Hisayuki Nakayama
Shuichi Nishihata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of AU2001258755A1 publication Critical patent/AU2001258755A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides an ophthalmic solution containing pranoprofen or a pharmacologically acceptable salt thereof, and a vasoconstrictor, which is effective for ameliorating congestion in outer ocular areas, particularly conjunctiva and pericorneal area.
AU2001258755A 2000-05-17 2001-05-16 Ophthalmic solution Abandoned AU2001258755A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-145641 2000-05-17
JP2000145641 2000-05-17
PCT/JP2001/004084 WO2001087304A1 (en) 2000-05-17 2001-05-16 Ophthalmic solution

Publications (1)

Publication Number Publication Date
AU2001258755A1 true AU2001258755A1 (en) 2001-11-26

Family

ID=18652119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258755A Abandoned AU2001258755A1 (en) 2000-05-17 2001-05-16 Ophthalmic solution

Country Status (10)

Country Link
EP (1) EP1283043B1 (en)
JP (2) JP4737911B2 (en)
KR (1) KR100776577B1 (en)
CN (1) CN1270707C (en)
AT (1) ATE383147T1 (en)
AU (1) AU2001258755A1 (en)
DE (1) DE60132325T2 (en)
ES (1) ES2295161T3 (en)
PT (1) PT1283043E (en)
WO (1) WO2001087304A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5456234B2 (en) 2003-06-30 2014-03-26 アルザ・コーポレーシヨン Formulations for coated microprojections containing non-volatile counterions
JP4961671B2 (en) * 2004-02-27 2012-06-27 大正製薬株式会社 Eye drops
JP2005239681A (en) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd Ophthalmic agent
JP5434981B2 (en) * 2004-02-27 2014-03-05 大正製薬株式会社 Eye drops
JP2005247802A (en) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd Eye drops
JP4919666B2 (en) * 2005-01-26 2012-04-18 ロート製薬株式会社 Planoprofen-containing composition
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
WO2008026756A1 (en) * 2006-08-28 2008-03-06 Senju Pharmaceutical Co., Ltd. Ophthalmic percutaneous absorption type preparation
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
CN114099505B (en) * 2021-12-07 2023-10-27 湖北远大天天明制药有限公司 Ophthalmic composition, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184013A (en) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd Eye drop
JP2824863B2 (en) * 1989-07-12 1998-11-18 エーザイ株式会社 α ▲ Lower 1 ▼ -Blocker eye drops
JPH04327533A (en) * 1991-04-23 1992-11-17 Lion Corp Anti-allergic agent for locally administering to mucosa
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
JP4737911B2 (en) 2011-08-03
KR20030001490A (en) 2003-01-06
EP1283043B1 (en) 2008-01-09
PT1283043E (en) 2008-02-07
ES2295161T3 (en) 2008-04-16
JP2011093923A (en) 2011-05-12
EP1283043A4 (en) 2003-07-02
CN1438886A (en) 2003-08-27
CN1270707C (en) 2006-08-23
DE60132325D1 (en) 2008-02-21
EP1283043A1 (en) 2003-02-12
WO2001087304A1 (en) 2001-11-22
KR100776577B1 (en) 2007-11-16
DE60132325T2 (en) 2009-01-02
ATE383147T1 (en) 2008-01-15

Similar Documents

Publication Publication Date Title
USD419887S (en) Bottle
USD445714S1 (en) Necklace
USD497810S1 (en) Bottle
USD466979S1 (en) Tap
AU2001258755A1 (en) Ophthalmic solution
USD488214S1 (en) Deodorizing device for a refrigerator
HK1068962A1 (en) Multifocal ophthalmic lenses
USD479090S1 (en) Pitcher
BR0017157A (en) 6-hydroxy-indazole derivatives for the treatment of glaucoma
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2002232437A1 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
WO2003013294A3 (en) Garment with protected deformable inserts
USD466995S1 (en) Earplug
USD457439S1 (en) Bottle
ITRM20010438A0 (en) OPHTHALMIC PREPARATION BASED ON N-ACETYLCYSTEINE FOR THE TREATMENT OF DRY EYE SYNDROME.
WO2004028451A3 (en) β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA
USD522875S1 (en) Bottle
USD431586S (en) Sunglasses
CA2414586A1 (en) Agent for therapeutic treatment of optic nerve diseases and the like
USD468211S1 (en) Bottle
USD473627S1 (en) Knife
USD453459S1 (en) Scissors
USD492127S1 (en) Lighted mirror
USD475241S1 (en) Tap for drinks
USD453967S1 (en) Ophthalmic occluder